跳至主要内容
临床试验/EUCTR2014-000967-42-NL
EUCTR2014-000967-42-NL
进行中(未招募)
1 期

Strengthening memory immunity in the aged population by vaccinating re-elderly - StimulAge study

ational Institute for Public Health and the Environment (RIVM)0 个研究点目标入组 250 人2014年5月12日
相关药物NimenrixZostavax

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
ational Institute for Public Health and the Environment (RIVM)
入组人数
250
状态
进行中(未招募)
最后更新
6年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2014年5月12日
结束日期
待定
最后更新
6年前
研究类型
Interventional clinical trial of medicinal product

研究者

发起方
ational Institute for Public Health and the Environment (RIVM)

入排标准

入选标准

  • In order to be eligible to participate in this study, participants must meet
  • all of the following criteria:
  • General good health
  • 50\-65 years of age
  • Provision of written informed consent;
  • Adherent to protocol and available during the study period.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 250

排除标准

  • Any of the following criteria will exclude a participant from this study:
  • Antibiotic use within 14 days of enrollment;
  • Present evidence of serious disease(s) demanding immunosuppressive
  • medical treatment, like corticosteroids, that might interfere with the
  • results of the study within the last 3 months;
  • Known or suspected allergy to any of the vaccine components (by
  • medical history);
  • Occurrence of serious adverse event after other vaccination (by
  • medical history);
  • Known or suspected immune deficiency;

结局指标

主要结局

未指定

相似试验